Financials

  • Market Capitalization N/A
  • Employee 713
  • Founded 2013
  • CEO Thomas Lingelbach
  • Website www.valneva.com
  • Headquarter France
  • FIGI BBG00ZZPBH08
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
Price to sales ratio
Dividends per share
Dividend yield %

Valneva SE - American Depositary Shares

Valneva SE is a specialty vaccine company registered in Saint-Herblain, France, developing, producing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States.

Новости